Transoral Incisionless Fundoplication (TIF), performed with the EsophyX® device, is a less invasive procedural option designed to treat the symptoms of GERD while minimizing post-operative side effects. To date, the TIF procedure has been performed in more than 18,000 patients and has been documented in over 70 scientific publications evaluating outcomes of more than 1,200 unique patients.
Brands: EsophyX® Device
DDW Tracks Technologies and Procedural Innovations
Does your company only service US attendees? Yes
Is your company a new exhibiting company? No